Skip to content

Survival of the Cementless Spotorno total hip arthroplasty

Survival of the Cementless Spotorno total hip arthroplasty - CLS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON38627
Enrollment
102
Registered
2013-07-04
Start date
2013-11-27
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip replacement total hip arthroplasty

Interventions

None listed

Sponsors

Meander Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients who received an uncemented hip prosthesis type Cementless Spotorno between 1989 and 1997 and previously included in the prospective cohort study.

Exclusion criteria

Exclusion criteria: The exclusion criterion for the long-term follow up is not being previously included in the prospective cohort study.

Design outcomes

Primary

MeasureTime frame
The primairy endpoint is revision of the total hip arthroplasty for any reason.

Secondary

MeasureTime frame
Revision of the total hip arthroplasty because of aseptic loosening, septic loosening, instability or fracture. Clinical outcome using Charnley*s modification of the Merle d*Aubigné-Postel, Harris Hip score and the EQ5D questionnaire Radiological geometrical assessment: The acetabular cup inclination angle and degree and angle of linear polyethylene wear and heterotopic ossifications on X-ray. Effects of preoperative clinical status, patient demographics, prosthetic component size, and polyethylene wear on clinical outcome, aseptic loosening and revision for any reason.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)